Literature DB >> 2809212

A novel polypeptide secreted by activated human T lymphocytes.

M D Miller1, S Hata, R De Waal Malefyt, M S Krangel.   

Abstract

We have identified two cDNA clones, I-309 and G-26, which define genes expressed abundantly in activated human PBMC, but at low or undetectable levels in resting PBMC. Based upon nucleotide sequence analysis, both clones are predicted to encode small, structurally related polypeptides, each containing a hydrophobic leader sequence characteristic of secreted proteins and a motif of four conserved cysteine residues. Further, I-309 and G-26 are structurally related to a growing family of genes that apparently encode small polypeptides whose secretion is induced upon cell activation. I-309 represents a previously undescribed human gene. We have generated an anti-peptide antiserum to the I-309 gene product which recognizes proteins in culture supernatants of an activated T cell clone and of COS cells transfected with the I-309 cDNA, supporting the idea that I-309 encodes a secreted protein. Because I-309 encodes a small protein secreted by activated T cells that displays structural features similar to other cytokines, we believe that it defines a novel cytokine with as yet unknown function.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809212

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  The human cytokine I-309 is a monocyte chemoattractant.

Authors:  M D Miller; M S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

3.  The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice.

Authors:  J A Anderson; A B Lentsch; D J Hadjiminas; F N Miller; A W Martin; K Nakagawa; M J Edwards
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

4.  Identification of cell surface receptors for the Act-2 cytokine.

Authors:  M Napolitano; K B Seamon; W J Leonard
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

5.  Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues.

Authors:  J H Gong; I Clark-Lewis
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

6.  Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes.

Authors:  A Orlofsky; M S Berger; M B Prystowsky
Journal:  Cell Regul       Date:  1991-05

7.  C-terminal clipping of chemokine CCL1/I-309 enhances CCR8-mediated intracellular calcium release and anti-apoptotic activity.

Authors:  Catherine Denis; Kathleen Deiteren; Anneleen Mortier; Amel Tounsi; Erik Fransen; Paul Proost; Jean-Christophe Renauld; Anne-Marie Lambeir
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

8.  A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus molluscum contagiosum.

Authors:  H R Lüttichau; J Stine; T P Boesen; A H Johnsen; D Chantry; J Gerstoft; T W Schwartz
Journal:  J Exp Med       Date:  2000-01-03       Impact factor: 14.307

Review 9.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

10.  The human cutaneous chemokine system.

Authors:  Michelle L McCully; Bernhard Moser
Journal:  Front Immunol       Date:  2011-08-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.